Literature DB >> 22417834

Fentanyl: toxic or therapeutic? Postmortem and antemortem blood concentrations after transdermal fentanyl application.

Hilke Andresen1, Annemarie Gullans, Michele Veselinovic, Sven Anders, Achim Schmoldt, Stefanie Iwersen-Bergmann, Alexander Mueller.   

Abstract

In forensic toxicology, several fatal intoxications with fentanyl have occurred in the recent past, but there are rare discussions in the literature of postmortem fentanyl blood concentrations subsequent to lethal and non lethal applications. To study this problem, we analyzed postmortem blood concentrations (vena femoralis) of 118 cases with therapeutic use of fentanyl and compared them with serum levels of 27 living persons after therapeutic administration of fentanyl patches (Durogesic). Basically, blood concentrations in postmortem specimens cannot be directly compared with in vivo serum levels: in our study, we observed that postmortem fentanyl blood concentrations were on average up to nine times higher than in vivo serum levels at the same dose. These differences could be explained by postmortem redistribution, but they were higher than expected on the basis of the physical and chemical properties of fentanyl alone. The special pharmacokinetics of the drug after long term transdermal application seem to play an important role in this phenomenon. In addition, there was no clear correlation between transdermal fentanyl dose and blood or serum concentrations, either antemortem or postmortem. Our study provides extensive data for postmortem peripheral blood concentrations after therapeutic non-fatal fentanyl patch application and demonstrates once more that in forensic toxicology, blood concentrations must be holistically interpreted with respect to all aspects of a case.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22417834     DOI: 10.1093/jat/bks005

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  8 in total

1.  Antemortem and postmortem fentanyl concentrations: a case report.

Authors:  Iain M McIntyre; Ray D Gary; Julio Estrada; Craig L Nelson
Journal:  Int J Legal Med       Date:  2013-07-24       Impact factor: 2.686

2.  Reliability of postmortem fentanyl concentrations in determining the cause of death.

Authors:  James R Gill; Peter T Lin; Lewis Nelson
Journal:  J Med Toxicol       Date:  2013-03

3.  Death by band-aid: fatal misuse of transdermal fentanyl patch.

Authors:  Marija Bakovic; Marina Nestic; Davor Mayer
Journal:  Int J Legal Med       Date:  2015-06-09       Impact factor: 2.686

4.  Assisted suicide by fentanyl intoxication due to excessive transdermal application.

Authors:  Martin Juebner; Mathias Fietzke; Justus Beike; Markus A Rothschild; Katja Bender
Journal:  Int J Legal Med       Date:  2014-02-28       Impact factor: 2.686

5.  Quantitative low-volume assay for simultaneous determination of fentanyl, norfentanyl, and minor metabolites in human plasma and urine by liquid chromatography-tandem mass spectrometry (LC-MS/MS).

Authors:  Nina Sophia Mahlke; Victoria Ziesenitz; Gerd Mikus; Gisela Skopp
Journal:  Int J Legal Med       Date:  2014-07-06       Impact factor: 2.686

6.  Complete republication: National Association of Medical Examiners position paper: Recommendations for the investigation, diagnosis, and certification of deaths related to opioid drugs.

Authors:  Gregory G Davis
Journal:  J Med Toxicol       Date:  2014-03

Review 7.  Postmortem Toxicology of New Synthetic Opioids.

Authors:  Marta Concheiro; Rachel Chesser; Justine Pardi; Gail Cooper
Journal:  Front Pharmacol       Date:  2018-10-26       Impact factor: 5.810

8.  Higher naloxone dosing in a quantitative systems pharmacology model that predicts naloxone-fentanyl competition at the opioid mu receptor level.

Authors:  Ronald B Moss; Meghan McCabe Pryor; Rebecca Baillie; Katherine Kudrycki; Christina Friedrich; Mike Reed; Dennis J Carlo
Journal:  PLoS One       Date:  2020-06-16       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.